Volume 20 Number 9
30 September 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 9, 30 September

Li K, Lu D, Guo Y, Wang C, Liu X, Liu Y, Liu D.
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014.
Cancer Med. 2018 Sep 2,
2018;7(10):5281-5290. doi: 10.1002/cam4.1757. PMID: 30175510. Observational study. ˍ

Palmer JD, Bhamidipati D, Song A, Eldredge-Hindy HB, Siglin J, Dan TD, Champ CE, Zhang I, Bar-Ad V, Kim L, Glass J, Evans JJ, Andrews DW, Werner-Wasik M, Shi W.
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
J Neurooncol. 2018 Sep 4, 2018;140(3):623-628. doi: 10.1007/s11060-018-2989-z. PMID: 30182159. Observational study. ˍ

Majchrzak K, Bobek-Billewicz B, Hebda A, Majchrzak H, Ładziński P, Krawczyk L.
Surgical treatment and prognosis of adult patients with brainstem gliomas.
Neurol Neurochir Pol. 2018 Sep 5, 2018;52(5):623-633. doi: 10.1016/j.pjnns.2018.08.008. PMID: 30213445. Observational study. ˍ

Sadik ZHA, Hanssens PEJ, Verheul JB, Beute GN, Te Lie S, Leenstra S, Ardon H.
Gamma knife radiosurgery for recurrent gliomas.
J Neurooncol. 2018 Sep 6,
2018;140(3):615-622. doi: 10.1007/s11060-018-2988-0. PMID: 30191361. Observational study. ˍ

Cui P, Ma X, Li H, Lang W, Hao J.
Shared Biological Pathways Between Alzheimer's Disease and Ischemic Stroke.
Front Neurosci. 2018 Sep 7, 2018;12:605. doi: 10.3389/fnins.2018.00605. PMID: 30245614. Laboratory investigation. ˍ

Callovini GM, Telera S, Sherkat S, Sperduti I, Callovini T, Carapella CM.
How is stereotactic brain biopsy evolving? A multicentric analysis of a series of 421 cases treated in Rome over the last sixteen years.
Clin Neurol Neurosurg. 2018 Sep 13, 2018;174:101-107. doi: 10.1016/j.clineuro.2018.09.020. PMID: 30227295. Observational study. ˍ

Aydemir F, Kardes O, Hasbay B, Sedef AM, Tufan K, Kayaselçuk F.
Multiple Extraneural Metastases of Anaplastic Oligodendroglioma.
Asian J Neurosurg. 2018 Sep 14, 2018;13(3):830-833. doi: 10.4103/1793-5482.238010. PMID: 30283558. Case report. ˍ

Arcella A, Oliva MA, Staffieri S, Sanchez M, Madonna M, Riozzi B, Esposito V, Giangaspero F, Frati L.
Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro and in vivo study.
Environ Toxicol. 2018 Sep 15, 2018;33(11):1160-1167. doi: 10.1002/tox.22622. PMID: 30218594. Laboratory investigation. ˍ

Jakati S, Jyotsna RY, Purohit AK, Sundaram C.
Medulloblastoma with extensive nodularity: A rare variant with a favorable outcome.
Neurol India. 2028 Sep 17, 2018;66(5):1517-1518. doi: 10.4103/0028-3886.241357. PMID: 30233042. Case report. ˍ

Arslanca SB, Söylemez F, Koç A.
Congenital glioblastoma multiforme presented with intracranial bleeding: a case report.
J Obstet Gynaecol. 2018 Sep 18, 2019;39(3):427-428. doi: 10.1080/01443615.2018.1475470. PMID: 30226408. Case report. ˍ

Nguyen HT, Nguyen N, Liu LY, Dovek L, Lenchner D, Harris R, Ozer B, Ravelo A, Sommer N, Sim MS, Elashoff R, Green R, Nghiemphu PL, Cloughesy TF, Ellingson B, Lai A.
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Neurooncol Pract. 2018 Sep 20, 2019;6(2):103-111. doi: 10.1093/nop/npy021. PMID: 31386050. Observational study. ˍ

Schwartz C, Romagna A, Machegger L, Weiss L, Huemer F, Fastner G, Kleindienst W, Serge W, Greil R, Winkler PA.
Extensive leptomeningeal intracranial and spinal metastases in a patient with a supratentorial glioblastoma multiforme, IDH-wildtype: A case report.
World Neurosurg. 2018 Sep 22, 2018;120:442-447. doi: 10.1016/j.wneu.2018.09.082. PMID: 30253992. Case report. ˍ

Tanaka S, Hitotsumatsu T, Sugita Y, Ishido K, Ito O, Hatae R, Akagi Y, Yoshimoto K, Iihara K.
Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Pathol Int. 2018 Sep 23, 2018;68(10):567-573. doi: 10.1111/pin.12723. PMID: 30246385. Case report. ˍ

Zhao M, Wang X, Fu X, Zhang Z.
Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma.
J Cancer Res Ther. 2018 Sep 24, 2018;14(10):789-792. doi: 10.4103/jcrt.JCRT_990_15. PMID: 30249905. Case report. ˍ

Alhajala HS, Nguyen HS, Shabani S, Best B, Kaushal M, Al-Gizawiy MM, Erin Ahn EY, Knipstein JA, Mirza S, Schmainda KM, Chitambar CR, Doan NB.
Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes.
Oncotarget. 2018 Sep 25, 2018;9(75):34122-34131. doi: 10.18632/oncotarget.26137. PMID: 30344926. Laboratory investigation. ˍ

Buchmann N, Gempt J, Ryang YM, Pyka T, Kirschke JS, Meyer B, Ringel F.
Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?
World Neurosurg. 2018 Sep 27, 2019;121:e467-e474
. doi: 10.1016/j.wneu.2018.09.139. PMID: 30267942. Observational study. ˍ

Verschuur A, Heng-Maillard MA, Dory-Lautrec P, Truillet R, Jouve E, Chastagner P, Leblond P, Aerts I, Honoré S, Entz-Werle N, Sirvent N, Gentet JC, Corradini N, André N.
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial.
Front Pharmacol. 2018 Sep 27, 2018;9:00950. doi: 10.3389/fphar.2018.00950. PMID: 30319400. Interventional study. ˍ

Brandes AA, Gil-Gil M, Saran F, Carpentier AF, Nowak AK, Mason W, Zagonel V, Dubois F, Finocchiaro G, Fountzilas G, Cernea DM, Chinot O, Anghel R, Ghiringhelli F, Beauchesne P, Lombardi G, Franceschi E, Makrutzki M, Mpofu C, Urban HJ, Pichler J.
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
Oncologist. 2018 Sep 28, 2019;24(4):521-528. doi: 10.1634/theoncologist.2018-0290. PMID: 30266892. Interventional study. ˍ